Skip Navigation


The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Bookmark | Print | E-Mail

Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Immunology/Infectious Diseases | Musculoskeletal | Rheumatology | Dermatology/Plastic Surgery

Lupus

Alabama

Huntsville : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

California

La Jolla : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

La Jolla : University of California San Diego University of California San Diego

The ACCESS Trial for lupus with kidney disease (lupus nephritis)

Los Angeles : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Los Angeles : Cedars Sinai Medical Center

The ACCESS Trial for lupus with kidney disease (lupus nephritis)

San Francisco : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

San Francisco : University of California San Francisco

The ACCESS Trial for lupus with kidney disease (lupus nephritis)

San Leandro : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Torrance : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Florida

Clearwater : Clinical Research of West Florida, Inc.

ABOUT LUPUS

Miami : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Miami : University of Miami. Florida University of California San Diego

The ACCESS Trial for lupus with kidney disease (lupus nephritis)

Georgia

Atlanta : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Idaho

Boise : Covance

Lupus (SLE)

Boise : Covance

Lupus (SLE)

Illinois

Chicago : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Maryland

Baltimore : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Chevy Chase : The Center for Rheumatology and Bone Research - Chevy Chase, MD

Do you have Lupus?

Laurel : The Center for Rheumatology and Bone Research - Laurel, MD

Do you have Lupus?

Rockville : The Center for Rheumatology and Bone Research - Rockville, MD

Do you have Lupus?

Wheaton : The Center for Rheumatology and Bone Research - Wheaton, MD

Do you have Lupus ?

Massachusetts

Boston : Brigham & Women's Hospital

The ACCESS Trial for lupus with kidney disease (lupus nephritis)

Michigan

Ann Arbor : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Detroit : Wayne State University

The ACCESS Trial for lupus with kidney disease (lupus nephritis)

Missouri

Columbia : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

New York

Brooklyn : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Lake Success : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Lake Success : Biomedical Research Alliance of New York

Lupus - Adults

Lake Success : Biomedical Research Alliance of New York New!

Lupus - Adults

Manhasset : Biomedical Research Alliance of New York

Lupus – SLE (SYSTEMIC LUPUS ERYTHEMATOSUS) - Adults

Manhasset : Biomedical Research Alliance of New York

Renal Disease- Systemic Lupus

Manhasset : Feinstein Institute Recruiting University of California San Diego

The ACCESS Trial for lupus with kidney disease (lupus nephritis)

New York : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

New York : Biomedical Research Alliance of New York

Systemic Lupus Erythematosus (SLE) - Adults and minors

New York : Sleligman Center for Advanced Therapeutics (NYU)

The ACCESS Trial for lupus with kidney disease (lupus nephritis)

Rochester : AAIR Research Center

Lupus Study for lupus patients who have lupus kidney disease

Rochester : University of Rochester

The ACCESS Trial for lupus with kidney disease (lupus nephritis)

North Carolina

Chapel Hill : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Chapel Hill : UNC, Chapel Hill

The ACCESS Trial for lupus with kidney disease (lupus nephritis)

Pittsburgh : University of Pittsburgh Lupus Center of Excellence

The ACCESS Trial for lupus with kidney disease (lupus nephritis)

Ohio

Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation

Ovary Protection Medication Study for Childhood Onset Lupus (ages 21 and under).

Cleveland : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Columbus : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Oklahoma

Oklahoma City : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Oklahoma City : Bone & Joint Hospital Research Dept

Lupus

Oklahoma City : Oklahoma Medical Research Foundation

The ACCESS Trial for lupus with kidney disease (lupus nephritis)

Pennsylvania

Philadelphia : Temple University

The ACCESS Trial for lupus with kidney disease (lupus nephritis)

Pittsburgh : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

South Carolina

Charleston : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Texas

Dallas : Metroplex Clinical Research Center

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Rituximab in Subjects with ISN/RPS Class III or IV Lupus Nephritis

Dallas : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Dallas : UT Southwestern

The ACCESS Trial for lupus with kidney disease (lupus nephritis)

Washington, DC

Washington : The Center for Rheumatology and Bone Research - Washington, DC

Do you have Lupus?

Argentina

Buenos Aires : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Córdoba : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Tucuman : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Australia

Adelaide : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Sydney : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Belgium

Bruxelles : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Leuven : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Brazil

Rio De Janeiro : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Sao Paulo : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Sorocaba : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Canada

Halifax, NS : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

London, ON : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Montreal, QC : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Toronto, ON : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Vancouver, BC : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

China

Beijing : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Guangzhou : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Guangzhou : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.

Shanghai : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Czech Republic

Brno : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

France

Lille : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Lyon : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Nantes : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Paris : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Toulouse : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Germany

Aachen : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Bad Bramstedt : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Berlin : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Dresden : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Hannover : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Leipzig : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Muenster : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

München : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Greece

Athens : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Heraklion : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Hungary

Pécs : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Italy

Brescia : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Milano : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Padova : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Pisa : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Udine : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Mexico

Merida : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Mexico City : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

San Luis Potosi : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Portugal

Lisboa : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Porto : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Spain

Alicante : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Barcelona : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Madrid : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Malaga : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Santander : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Sevilla : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

United Kingdom

Birmingham : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Leeds : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

London : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Manchester : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Newcastle upon Tyne : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Sheffield : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Southampton : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Venezuela

Barquisimeto : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.

Caracas : Research Site:

A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.


Jobson Medical Information

Copyright © 1995-2009 Jobson Medical Information LLC.


Designed by Piehead Productions LLC.